Author:
Steininger Julian,Günther Claudia
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Wiendl H., Schmidt J. et al., Myositissyndrome, S2k-Leitlinie, 2022; in: Deutsche Gesellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 2. Aug. 2023).
2. Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372(18):1734–1747
3. Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J et al (2018) The euromyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30–39
4. Aussy A, Boyer O, Cordel N (2017) Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer. Front Immunol 8:992
5. Furst DE, Amato AA, Iorga ŞR, Gajria K, Fernandes AW (2012) Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve 45(5):676–683